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Abstract
Background: P450 oxidoreductase (POR) catalyzes electron transfer to microsomal P450 enzymes. Its
deficiency causes Antley-Bixler syndrome (ABS), and about half the patients with ABS have ambiguous
genitalia and/or impaired steroidogenesis. POR mRNA expression is up-regulated when mesenchymal
stem cells (MSCs) differentiate into steroidogenic cells, suggesting that the regulation of POR gene
expression is important for steroidogenesis. In this context we examined the regulation of POR
expression in ovarian granulosa cells by gonadotropins, and its possible role in steroidogenesis.
Methods: Changes in gene expression in MSCs during differentiation into steroidogenic cells were
examined by DNA microarray analysis. Changes in mRNA and protein expression of POR in the rat ovary
or in granulosa cells induced by gonadotropin treatment were examined by reverse transcription-
polymerase chain reaction and western blotting. Effects of transient expression of wild-type or mutant
(R457H or V492E) POR proteins on the production of estrone in COS-7 cells were examined in vitro.
Effects of POR knockdown were also examined in estrogen producing cell-line, KGN cells.
Results: POR mRNA was induced in MSCs following transduction with the SF-1 retrovirus, and was
further increased by cAMP treatment. Expression of POR mRNA, as well as Cyp19 mRNA, in the rat ovary
were induced by equine chorionic gonadotropin and human chorionic gonadotropin. POR mRNA and
protein were also induced by follicle stimulating hormone in primary cultured rat granulosa cells, and the
induction pattern was similar to that for aromatase. Transient expression of POR in COS-7 cells, which
expressed a constant amount of aromatase protein, greatly increased the rate of conversion of
androstenedione to estrone, in a dose-dependent manner. The expression of mutant POR proteins
(R457H or V492E), such as those found in ABS patients, had much less effect on aromatase activity than
expression of wild-type POR proteins. Knockdown of endogenous POR protein in KGN human granulosa
cells led to reduced estrone production, indicating that endogenous POR affected aromatase activity.
Conclusion: We demonstrated that the expression of POR, together with that of aromatase, was
regulated by gonadotropins, and that its induction could up-regulate aromatase activity in the ovary,
resulting in a coordinated increase in estrogen production.
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Background
The ovary is one of the major steroidogenic organs, and
ovarian follicular development is initiated by follicle stim-
ulating hormone (FSH) secreted by the pituitary gland.
FSH-induced follicular development involves granulosa
cell proliferation and differentiation [1,2]. FSH induces
steroidogenic enzymes in ovarian granulosa cells leading
to the production of steroid hormones, including estro-
gens. P450 aromatase (CYP19) is one of the steroidogenic
enzymes regulated by FSH, and catalyzes the biosynthesis
of estrogens from C19 steroids in the granulosa cells [3].
P450 oxidoreductase (POR) is an 82-kDa membrane-
bound flavoprotein [4,5] responsible for the transfer of
electrons from nicotine adenine dinucleotide phosphate
to flavin adenine dinucleotide (FAD) and flavin mononu-
cleotide (FMN), and finally to microsomal P450 enzymes,
including aromatase, as well as to several non-P450
enzymes [6,7]. Several clinical studies have reported that
mutations in POR are sufficient to cause Antley-Bixler syn-
drome (ABS), which is characterized by skeletal malfor-
mations. In some cases, ABS patients have genital
ambiguity, and in some of the cases female ABS patients
present with polycystic ovary syndrome [6,8-11]. The clin-
ical features are primarily explained by the impaired activ-
ities of CYP21A2, CYP17A1, and CYP19 involved in
steroidogenesis [11,12].
Bone marrow-derived mesenchymal stem cells (MSCs)
are defined as pluripotent cells, and have been shown to
differentiate into adipocytes, chondrocytes, osteoblasts,
and hematopoietic-supporting stroma, both in vivo and
ex vivo [13-15]. We recently reported that stable transfec-
tion of MSCs with the transcription factor, steroidogenic
factor-1 (SF-1), followed by treatment with cAMP, led to
their conversion into steroidogenic cells [16]. These cells
offer a possible clinical source of stem cells for the treat-
ment of diseases of steroidogenic organs, and represent a
powerful tool for studying the differentiation of the ster-
oidogenic lineage.
In this study, we investigated the changes in gene expres-
sion in MSCs during differentiation into steroidogenic
cells. POR gene expression, as well as that of various ster-
oidogenic enzymes, was induced by SF-1 and cAMP. It was
also induced by gonadotropins in rat ovary and granulosa
cells. We also examined the effects of wild-type and
mutant POR expression on aromatase activity, and the
effects of knockdown of endogenous POR in mammalian
cell lines. Our results suggest that up-regulation of POR
expression by gonadotropins, as well as that of aromatase,
could enhance ovarian estrogen synthesis.
Methods
Diethylstilbestrol (DES), 8-bromoadenosine 3'-5'-cyclic
monophosphate (8-Br-cAMP), and gentamicin were pur-
chased from Sigma (St. Louis, MO). Ovine FSH was
obtained from the National Institutes of Health (NIH).
Equine chorionic gonadotropin (eCG) was purchased from
Teikokuzouki, Inc. (Tokyo, Japan). Human chorionic
gonadotropin (hCG) was obtained from Sankyo (Tokyo,
Japan). Ex Taq DNA polymerase, Escherichia coli DNA
ligase, and DNA ligation kit were purchased from Takara
Biomedicals (Kyoto, Japan). Ham's F-12/DMEM and
DMEM were purchased from Wako Chemicals (Tokyo,
Japan). Reagents for real-time polymerase chain reaction
(PCR) were purchased from Applied Biosystems (Foster,
CA). HiPerFect Transfection Reagent and fluorescently
labeled high-performance purity grade small interfering
RNA (siRNA), used for transfection control, were pur-
chased from QIAGEN (Valencia, CA). The QuikChange
site-directed mutagenesis kit and Pfu DNA polymerase
were purchased from Stratagene (La Jolla, CA). Genopure
Plasmid Maxi Kit was purchased from Roche Applied Sci-
ence (Penzberg, Germany). The Trizol reagent, Superscript
III reverse transcriptase, E. coli DNA polymerase, RNase H,
Lipofectamine Plus, pcDNA3 and pEF-1/V5-His A vectors
were purchased from Invitrogen (Carlsbad, CA). A Protein
Assay Kit was purchased from Bio-Rad Laboratories, Inc.
(Hercules, CA). Anti-POR (sc-25270) and anti-glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) (sc-32233)
antibodies were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA). Anti-aromatase (MCA2077S) anti-
body was purchased from AbD Serotec (Oxford, UK). The
enzyme immunoassay (EIA) kits for estrone and estradiol
were purchased from Cayman Chemical (Ann Arbor, MI).
SiRNAs for human POR, named POR #1 (Hs_POR-2,
SASI_Hs01_00216914) and POR #2 (Hs_POR-3,
SASI_Hs01_00216915), were purchased from Sigma-
Aldrich Japan (Tokyo, Japan). pQCXIP retroviral vector kit
was purchased from Clontech Laboratories (Palo Alto, CA).
Microarray analysis
UE7T-13 MSCs [17], transduced or untransduced with SF-
1 by retrovirus-mediated transfection, were cultured in
DMEM supplemented with 50 mg/l gentamicin sulfate
and 10% fetal bovine serum (FBS) in a humidified atmos-
phere containing 5% CO2 in 95% air at 37°C. Total RNA
was isolated with Trizol reagent and Oligotex. cDNA was
synthesized from total RNA using a Superscript III kit with
T7-(dT) 24-mer primer harboring a T7 RNA polymerase
promoter. The cRNA was then prepared using an Affyme-
trix GeneChip expression 3' amplification kit. Labeled
cRNA was fragmented by incubation at 94°C for 35 min.
Hybridization of cRNA for human U133 Plus 2.0 Affyme-
trix GeneChip and its analysis were performed as
described previously [18].
Rat granulosa cell culture
Granulosa cells were obtained from immature, SLC: SD
female rats (21 days old) that had received injections of 2
mg DES in 0.2 ml sesame oil once daily for 4 d. The ova-Reproductive Biology and Endocrinology 2008, 6:62 http://www.rbej.com/content/6/1/62
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ries were then excised and granulosa cells were released by
puncturing the follicles with a 26-gauge needle. Animals
were treated according to NIH guidelines and the experi-
ments were approved by the animal experiment commit-
tee of the University of Fukui. Granulosa cells were
washed and collected by brief centrifugation, and cell via-
bility was determined by trypan blue exclusion. The gran-
ulosa cells were then cultured in Ham's F-12/DMEM
supplemented with 50 mg/l gentamicin sulfate and 0.1%
bovine serum albumin on collagen-coated plates in a
humidified atmosphere containing 5% CO2 in 95% air at
37°C [19].
Hormone treatments and analysis of gene expression
Granulosa cells (5 × 106 cells) were cultured in 60-mm
dishes in 5 ml medium. Ovine FSH (30 ng/ml) was added
to the medium after 24 h of cell culture. The cultures were
stopped at various time intervals. For the in vivo study,
21-day-old rats were primed with 30 IU eCG. After 48 h,
the rats were primed with 30 IU hCG and ovaries were
removed at various time intervals. KGN cells (kindly
gifted by Dr. Toshihiko Yanase, Kyushu University, Fuku-
oka, Japan) were cultured in 60-mm dishes containing 7.5
× 106 cells in 5 ml medium and 8-Br-cAMP (final concen-
tration 1 mM) was added to the medium 24 h after plat-
ing. The cultures were stopped at various time intervals.
Total RNA was extracted from the cultured cells using Tri-
zol reagent. Reverse transcription-PCR (RT-PCR) was per-
formed as described previously [20]. The reaction mixture
was subjected to electrophoresis in a 1.5% agarose gel,
and the resulting bands were visualized by staining with
ethidium bromide. The primer pairs used were: forward
primer, 5'-caccacacctgtcatcatgg-3' (nucleotides 1612–
1631) and reverse primer, 5'-tgaggtcggcagaagttagg-3'
(nucleotides 2115–2134), for rat POR, product size: 523
bp (NM_031576); forward primer, 5'-ctggacgaaagttctattg-
3' (nucleotides 679–698) and reverse primer 5'-gaagcaa-
catgacgtacaga-3' (nucleotides 1000–1019), for Cyp19,
product size: 341 bp (NM_017085); and forward primer,
5'-ggacttctacgactggctgcagg-3' (nucleotides 541–563) and
reverse primer, 5'-tcttgttggactcctcatccagg-3' (nucleotides
1141–1163), for hPOR, product size: 623 bp
(NM_000941). The primer pairs for CYP19
(NM_000103), GAPDH (NM_002046), and beta-actin
(NM_001101.3) have been described previously [16].
Real-time PCR was performed as described by Rutledge
and Cote [21]. The primer pairs used were: forward
primer, 5'-ggagacgctgctgtactacg-3' (nucleotides 1765–
1784) and reverse primer, 5'-gctggacgtagaccttgtgg-3'
(nucleotides 1891–1912), for human POR, product size
146 bp; forward primer, 5'-ggacttcgagcaagagatgg-3'
(nucleotides 747–766) and reverse primer, 5'-aaggaaggct-
ggaagagtgc-3' (nucleotides 862–881), for human beta-
actin, product size 135 bp; forward primer, 5'-gatgacg-
ggaacttggaaga-3' (nucleotides 662–681) and reverse
primer, 5'-agctcatactggcgaatgct-3' (nucleotides 761–780),
for rat POR, product size 119 bp; forward primer, 5'-tcct-
cagcagagaaactggaaga-3' (nucleotides 857–879) and
reverse primer, 5'-cgtacagagtgacggacatggt-3', (nucleotides
986–1007) for cyp19, product size 151 bp; and forward
primer, 5'-ggcgacctggaagtccaact-3' (nucleotides 47–66)
and reverse primer, 5'-ggatctgctgcatctgcttg-3' (nucleotides
140–159), for rat 36B4, product size: 113 bp
(NM_022402).
Western blot analysis
In order to determine protein expression levels, granulosa,
KGN, and COS-7 cells (purchased from American type
culture collection) were washed twice in ice-cold phos-
phate-buffered saline and lysed in RIPA buffer (50 mM
Tris-HCl (pH 8.0) containing 1% Nonidet P-40, 0.1%
sodium dodecyl sulfate (SDS), 0.5% deoxycholate, and 1
mM phenylmethylsulfonyl fluoride). The cell debris was
removed by centrifugation at 15,000 × g at 4°C for 15
min, and supernatants were used as cell lysates. Proteins
were quantified using a Bio-Rad Protein Assay kit. Equal
amounts of protein (30 μg) were resolved by SDS-polyacr-
ylamide gel electrophoresis and transferred onto polyvi-
nylidene difluoride membranes. Western blot analysis of
POR, CYP19, and GAPDH was performed with antisera
directed against POR (raised against amino acids 1–300 of
human POR), CYP19 (synthetic peptide corresponding to
amino acids 376–390 of human CYP19), and GAPDH,
respectively. All antibodies were capable of reacting with
both human and rat antigens, respectively. Western blot
analysis of POR, aromatase, and GAPDH was performed
with antisera directed against POR, CYP19, and GAPDH,
respectively. Enhanced chemiluminescence western blot
reagents (Amersham Pharmacia Biotech, Arlington
Heights, IL) were used for detection.
Plasmid constructs
Entire coding regions of human and rat POR were gener-
ated by RT-PCR using cDNA from UE7T-13 cells stably
transfected with SF-1, and granulosa cells, respectively.
The coding regions were then subcloned into the expres-
sion vector, pcDNA3. Human CYP19 was generated by
RT-PCR using cDNA from KGN cells stimulated with 8-Br-
cAMP for 12 h, and subcloned into pEF-1. Primer pairs
used were: 5'-gagaGAATTCgccaccATGGATTACAAGGAT-
GACGACGATAAGggagactcccacgtgga-3' and 5'-gagaCTC-
GAGctagctccacacgtccaggg-3', for human POR; 5'-
gagaGAATTCgccaccATGGATTACAAGGATGACGACGA-
TAAGggggactctcacgaagac-3' and 5'-gagaCTCGAGctagctc-
cacacatctagtga-3', for rat POR; and 5'-gagaG ATATC g
ccaccATGGATTACAAGGATGACGACGATAAGgttttggaaat-
gctgaac-3' and 5'-gagaGCG GCCGCctagtgttccagacacctgtc-
3', for human CYP19. In order to obtain mutant human
PORs (R457H and V492E), site-directed mutagenesis of
the human POR was performed using the QuikChangeReproductive Biology and Endocrinology 2008, 6:62 http://www.rbej.com/content/6/1/62
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Site-Directed Mutagenesis Kit. Primer pairs used were: 5'-
gccgcgcctgcaggcccActactactccatcgcct-3' and 5'-aggcgatggag-
tagtagTgggcctgcaggcgcggc-3', for R457H; and 5'-ccgcat-
caacaagggcgAggccaccaactggctgc-3' and 5'-gcagccagttggt gg
ccTcgcccttgttgatgcgg-3', for V492E.
Transfection
COS-7 cells were cultured in DMEM supplemented with
antibiotics and 10% FBS in a humidified atmosphere con-
taining 5% CO2 and 95% air at 37°C. DNA transfections
were carried out using Lipofectamine Plus reagent. All
plasmids used for transfections were prepared using a
Genopure Plasmid Maxi Kit. Cells (4 × 105) were cultured
in 60-mm dishes in 5 ml medium on the day before trans-
fection. Three hours after co-transfection of human aro-
matase (1 μg/well) and rat POR (20, 50, or 100 ng/well)
or pcDNA3, medium was changed to growth medium.
After 48 h, the growth medium was changed to medium
containing androstenedione (final concentration 10-5 M).
Culture medium was collected at various time points in
order to observe the conversion of androstenedione to
estrone.
EIA
The levels of estrone in the media were measured using an
EIA assay kit (Cayman) according to the manufacturer's
instructions. Briefly, 50 μl of diluted medium (1:1000),
estrone tracer, and antiserum were added to each well.
They were incubated at room temperature for 2 h and
developed with Ellman's reagent solution. The developed
plates were measured using a plate reader at 405 nm.
SiRNA transfection
KGN cells were cultured in DMEM/Ham's F12 supple-
mented with antibiotics and 10% FBS in a humidified
atmosphere containing 5% CO2 and 95% air at 37°C.
Knockdown of endogenous POR was carried out using
siRNAs and HiPerFect reagent. Twenty-four hours after
transfection, the culture medium was changed to DMEM/
Ham's F12 supplemented with antibiotics and 10% FBS
containing 1 mM 8-Br-cAMP and 10 μM androstenedione.
Cells and medium were collected 48 h after transfection.
SiRNAs for POR were POR #1 (sense: 5' GCACAUCU-
GUGCGGUGGUUTT, anti sense: 5' AACCACCGCACA-
GAUGUGCTT) and POR #2 (sense: 5' CCAAC UGG
CUGCGGGCCAATT, anti sense: UUGGCCCGCAGCC
AGUUGGTT). They were targeted to the region approxi-
mately 1496 and 1568 nucleotides downstream from the
beginning of the human POR (Ref seq NM_000941),
respectively.
Statistics
Data from each experiment were analyzed using the Stu-
dent's t test. P < 0.01 was considered statistically signifi-
cant.
Results
Changes in gene expression in human MSCs during 
differentiation into steroidogenic cells
In previous studies, we converted MSCs into steroidogenic
cell-lineages such as Leydig cells and adrenocortical cells
by expression of SF-1 and treatment with cAMP [16]. DNA
microarray analysis was performed using control and SF-
1-transduced human MSCs in order to examine altera-
tions of gene expression. Using more than 22,000 probe
sets (18,400 transcripts and variants, including 14,500
well-characterized human genes), a number of differences
in gene expression levels between control cells and UE7T-
13 cells stably expressing SF-1 were detected: expression
levels of about 1,700 genes, including POR, were found to
be increased more than 5-fold in SF-1- transduced cells
(representative data from two independent experiments
are shown in Table 1). Gene expression of StAR [22],
Table 1: Subset of genes induced by SF-1 in UE7T-13 human 
mesenchymal stem cells.
Affymetrix ID Ratio Accession no. Gene Symbol
211506_s_at 488.85 AF043337 IL8
201262_s_at 463.31 BC002416 BGN
204309_at 362.16 NM_000781 CYP11A1
202411_at 274.98 NM_005532 IFI27
206294_at 225.3 NM_000198 HSD3B2
202036_s_at 160.06 AF017987 SFRP1
204548_at 153.41 NM_000349 STAR
220187_at 144.86 NM_024636 STEAP4
205498_at 96.03 NM_000163 GHR
202037_s_at 94.77 AF017987 SFRP1
203680_at 40.13 NM_002736 PRKAR2B
203632_s_at 40.06 NM_016235 GPRC5B
203475_at 32.4 NM_000103 CYP19A1
204415_at 31.5 NM_022873 IFI6
203903_s_at 24.23 NM_014799 HEPH
201010_s_at 20.95 NM_006472 TXNIP
213006_at 20.92 AV655640 CEBPD
201009_s_at 18.38 NM_006472 TXNIP
205027_s_at 17.9 NM_005204 MAP3K8
205635_at 15.66 NM_003947 KALRN
205502_at 14.89 NM_000102 CYP17A1
201981_at 14.76 AA148534 PAPPA
201416_at 14.15 NM_003107 SOX4
205302_at 13.77 NM_000596 IGFBP1
215233_at 11.12 AA351360 PTDSR
216117_at 10.42 AK025114 EXOSC2
203148_s_at 10.34 NM_014788 TRIM14
205404_at 8.66 NM_005525 HSD11B1
209540_at 8.52 M29644 IGF1
205676_at 8.51 NM_000785 CYP27B1
207135_at 8.41 NM_000621 HTR2A
210002_at 8.36 D87811 GATA6
204135_at 8.31 NM_014890 DOC1
208928_at 8.18 AF258341 POR
212095_s_at 7.41 BE552421 MTUS1
216248_s_at 6.24 S77154 NR4A2
206645_s_at 5.29 NM_000475 NR0B1Reproductive Biology and Endocrinology 2008, 6:62 http://www.rbej.com/content/6/1/62
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CYP11A1 [23], HSD3B2 [24], CYP19 [3], and CYP17A1
[25], whose transcriptions are known to be regulated by
SF-1, were induced. Consistent with the results of DNA
microarray, RT-PCR and real-time PCR analysis showed
that POR mRNA was markedly increased more than 20-
fold in UE7T-13 cells transduced with SF-1. It was further
induced by the addition of 8-Br-cAMP, and reached to
about 31-fold (Fig. 1A and 1B). These results indicate that,
concomitant with microsomal P450 genes, the POR gene
was induced during the differentiation of MSCs into ster-
oidogenic cells, and suggest that its up-regulation may
contribute to the development of the steroidogenic phe-
notype.
Induction of POR expression by gonadotropins in the 
ovary
In order to evaluate the relevance of above hypothesis, we
examined the expression of POR in the ovary and in gran-
ulosa cells, an organ and cells that are well known to be
involved in steroidogenesis or in the differentiation into
steroidogenic by gonadotropins. Ovarian POR mRNA was
detected at relatively low levels before gonadotropin treat-
ment. It was induced after 48 h of eCG treatment, and was
further increased within 2 h of the following hCG treat-
ment (Fig. 2A and 2B). Its expression then fell substan-
tially at 8 h, and continued to decline thereafter. The
pattern of POR expression induced by eCG and hCG was
similar to that of Cyp19 expression.
POR mRNA and proteins were strongly induced by FSH in
granulosa cells after 3–6 h. They fell temporarily at 12 h,
and then increased again from 24–48 h (Fig. 3A, B and
3C). Cyp19 mRNA and protein were barely detectable
before FSH treatment. They were strongly induced by FSH,
and followed a similar pattern to that of POR, although
Cyp19 levels responded more quickly than POR levels.
Consistent with the results from MSCs, POR was induced
in the ovary and granulosa cells when they were stimu-
lated to differentiate into steroidogenic cells by gonado-
tropins. Induction of Cyp19 protein by FSH causes
Induction of POR mRNA in human MSCs Figure 1
Induction of POR mRNA in human MSCs. A: RT-PCR 
analysis of POR mRNA in UE7T-13 cells transduced with SF-
1 or pQCXIP (control) virus and cultured with or without 8-
Br-cAMP for 2 d. B: Results of real-time PCR are also shown. 
Data are the mean ± SEM values of duplicate experiments.
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ovarian estrogen synthesis and follicle maturation [26].
These observations suggest that FSH-induced up-regula-
tion of POR expression, as well as that of Cyp19, could
enhance estrogen synthesis in granulosa cells.
Effects of POR expression on estrogen synthesis
In order to determine if estrogen synthesis was affected by
the level of POR expression when aromatase expression
remained constant, POR and aromatase expression vec-
tors were transiently co-transfected into COS-7 cells that
expressed an undetectable level of aromatase protein
(identified by Western blotting) and low levels of POR
expression (Fig. 4A and 4B). In order to investigate aro-
matase enzyme activity, we measured the conversion of
androstenedione to estrone in the culture medium.
Estrone levels were low and were unaffected by co-trans-
fection with both control vectors, or with the POR expres-
sion vector alone. However, time-dependent
accumulation of estrone occurred when aromatase was
expressed, and estrone levels were further increased by co-
transfection with the POR expression vector. Co-transfec-
tion with the aromatase expression vector and 100 ng of
the POR expression vector resulted in a 6-fold increase in
the amount of estrone converted in 6 h, compared with
the aromatase vector alone (Fig. 4A and 4B). These results
suggest that estrogen synthesis is up-regulated by increas-
Production of estrone by co-transfection of wild-type or mutant POR and aromatase expression vectors in COS-7 cells Figure 4
Production of estrone by co-transfection of wild-type or mutant POR and aromatase expression vectors in 
COS-7 cells. A and B: Amounts of estrone in the culture medium were detected by EIA at the indicated times and for the 
indicated contents of POR expression vector, with or without aromatase expression vector. The protein expression of POR, 
aromatase, and GAPDH after transfection with these amounts of vectors was detected by western blot analysis. C and D: 
COS-7 cells were transfected with wild-type POR or R457H or V492E mutant expression vectors (20 ng/well) with aromatase 
expression vector, at the indicated times. Data are means and SEM values (B) or SD values (D) of at least three assays, respec-
tively.
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ing levels of POR expression, even when aromatase
expression is constant.
We then examined the effects of the expression of mutant
POR genes on estrone production. It has been reported
that aromatase activity was completely lost when the
R457H or V492E POR mutant proteins were expressed
instead of the wild-type protein [27]. In COS-7 cells co-
transfected with R457H or V492E mutant POR and aro-
matase expression vectors, the amount of estrone was
reduced to 25% compared to co-transfection with wild-
type POR and aromatase. These estrone levels were similar
to those seen when aromatase was expressed alone (Fig.
4C and 4D). These results suggest that estrogen synthesis
is dependent not only on the expression levels of aro-
matase protein, but also on the expression levels of POR
protein.
Effects of knockdown of endogenous POR protein on 
estrogen production
We investigated the effects of knockdown of endogenous
POR by siRNA in granulosa cell-derived KGN cells.
Androstenedione and 8-Br-cAMP were added to the cul-
ture medium 24 h after transfection with 10 nM siRNA
and the amount of estrone in the medium was measured
after 48 h. In contrast to the rat granulosa cells, POR
expression was relatively high in KGN cells and was not
greatly changed by 8-Br-cAMP. Aromatase expression,
however, was induced by 8-Br-cAMP, as in rat granulosa
cells treated with FSH (Fig. 5A). POR siRNA caused a
reduction in the amount of estrone to about 70% of that
in cells transfected with a scrambled control siRNA (Fig.
5C). No estrone was detected in the absence of 8-Br-
cAMP.
Discussion
In our previous study, we reported that stable transfection
of MSCs with SF-1, followed by treatment with cAMP, led
to their conversion into steroidogenic cells [16]. These
cells offer a possible clinical source of stem cells for the
treatment of diseases of steroidogenic organs, and repre-
sent a powerful tool for studying the differentiation of the
steroidogenic lineage [16,28-30]. In this study, using DNA
microarray, RT-PCR, and real-time PCR analysis, we
observed that POR mRNA was induced during the differ-
entiation of hMSCs into steroidogenic cells. We also dem-
onstrated that the expression of the POR mRNA and
protein were up-regulated by FSH during the differentia-
tion of rat granulosa cells into steroidogenic cells. Similar
phenomena have been observed in adrenocortical cell
lines stimulated with adrenocorticotropic hormone
(ACTH) or cAMP [31,32]. These results suggest that POR
expression in steroidogenic cells is regulated by the pitui-
tary hormone/cAMP pathway. In contrast, it has been
reported that POR gene expression in hepatic cells and
other organs was not changed by any stimuli, including
cAMP, and in support of these observations, the promoter
region of the POR gene supported constitutively high luci-
ferase activity that was unaffected by any stimuli [33-36].
These results suggest that regulation of POR gene expres-
sion differs between steroidogenic and non-steroidogenic
cells. Although the reasons for this difference remain
unclear, the expression of SF-1 in steroidogenic cells may
explain this phenomenon. SF-1 is expressed in steroidog-
enic cells such as adrenocortical cells, testicular Leydig
cells, ovarian theca and granulosa cells, and regulates ster-
oidogenic genes that encode cytochrome P450scc, StAR
and CYP19, by binding to cAMP-response sequences
[3,22,23]. Our results from MSCs indicate that the POR
gene could represent a new target for SF-1 in steroidogenic
cells. It is therefore conceivable that the expression of POR
is regulated by the pituitary hormone/cAMP pathway.
Such regulations may also cause similar fluctuations in
POR and CYP19 expression in the ovary and in granulosa
cells. However, CYP19 mRNA was induced more rapidly
than POR mRNA, because the CYP19 gene is regulated by
CREB, as well as by SF-1 [3]. On the other hand, our pre-
liminary study indicated that CREB was not involved in
the induction of POR mRNA in granulosa cells by FSH
(data not shown). The POR gene spans more than 70 kb,
including an untranslated first exon residing about 38.8
Effect of POR knockdown on estrone production and cAMP  response of POR and aromatase genes in KGN cells Figure 5
Effect of POR knockdown on estrone production and 
cAMP response of POR and aromatase genes in KGN 
cells. After transfection with the indicated siRNAs, the cul-
ture medium was replaced with that containing 1 mM 8-Br-
cAMP and 10 μM androstenedione, and the amount of 
estrone in the culture medium was detected by EIA 48 h 
later (B and C). Data are means and SEM values of at least 
three assays. *, Significant difference in estrone production 
between KGN cells and KGN cells transfected siRNA for 
POR#1 or #2 (P < 0.01). The protein expression under these 
culture conditions at the indicated times is also shown (A and 
B).
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kb upstream of the coding region [4]. Further studies are
needed to understand the mechanisms regulating POR
gene expression.
Based on our observations in rat ovary and in granulosa
cells stimulated by gonadotropins, it is likely that increas-
ing POR expression induced by gonadotropins further up-
regulates aromatase activity, and that estrogen production
is regulated not only by aromatase expression, but also by
POR. This proposition is supported by the augmentation
of aromatase activity coincident with increasing POR
expression in COS-7 cells, despite a constant expression of
aromatase. Hall and his colleagues, using purified
enzymes, also reported that the activity of CYP17 was
increased by the addition of POR protein in a dose-
dependent manner, resulting in increased androgen pro-
duction [37]. Because almost all steroidogenic enzymes
are up-regulated by the pituitary hormone/cAMP path-
way, our model should be applicable to other microsomal
steroidogenic P450s, such as CYP17 and CYP21. In sup-
port of this hypothesis, CYP17 expression was markedly
increased, together with POR, in SF-1-transduced MSCs.
Similarly, the expression of ferredoxin, which is a member
of the electron transport chain in mitochondria and regu-
lates pregnenolone production by P450scc, is known to
be increased by pituitary hormones and cAMP [38-40].
Therefore, it is possible that, in addition to steroidogenic
enzyme expression, up-regulation of electron transporter
expression plays a vital role in steroid hormone produc-
tion by gonadotropins and ACTH. This mechanism
should be conserved between mitochondrial and micro-
somal steroidogenesis.
In COS-7 cells, a low level of estrone was detected in the
culture medium in the absence of transfection of CYP19,
even though aromatase proteins were not detected by
western blotting. COS cells (COS-1 and COS-7) have
often been used for measuring aromatase activity by
ectopic expression of the CYP19 gene, and low aromatase
activities have been reported under non-transfected con-
ditions [41-44]. It is thus conceivable that aromatase pro-
teins are expressed at very low levels in this cell line. It has
been reported that the R457H and V492E POR mutations
are associated with loss of P450 enzyme activities, because
these mutations in the FAD domain hamper the ability of
POR to transfer electrons to its FMN group, which ulti-
mately provides electrons to P450 enzymes [27]. When
these mutants were expressed concomitantly with aro-
matase in COS-7 cells, estrone production was similar to
that seen with aromatase alone. This result indicates that
the augmentation of aromatase activity by POR is not a
side effect of overexpression of POR, but is due to the
increased electron supply resulting from increased POR
expression in COS-7 cells.
FSH, forskolin, and cAMP have been reported to cause
increases in aromatase activity in KGN cells (a human
ovarian granulosa-like tumor cell line), as well as in rat
granulosa cells [45,46]. In contrast, POR expression in
KGN cells was little changed by 8-Br-cAMP treatment, and
was much higher than in primary cultures of rat granulosa
cells. In addition, it has been reported that the lower
amount of POR protein, compared with the amount of
P450 protein, was still sufficient to carry out all metabolic
reactions [47]. Hence, the amount of POR expression after
inhibition by siRNA, still seemed to be sufficient to acti-
vate aromatase induced by 8-Br-cAMP. Therefore, estrone
production should not be greatly reduced by POR siRNA.
POR is involved not only in steroidogenesis, but also in
drug and xenobiotic metabolism, and in tumorigenesis
[48,49]. It is likely that the hormone-responsiveness of
the POR gene is lost during immortalization of KGN cells.
However, induction of POR in granulosa cells may play a
more significant role in estrogen production, because the
amount of POR protein in these cells is limited. In granu-
losa cells, POR and aromatase expression are regulated by
gonadotropins, which in turn may be responsible for
coordinated regulation of steroid hormone production at
each stage of follicular growth.
In this study, we have demonstrated that estrogen produc-
tion was caused not only by aromatase expression, but
also through the promotion of aromatase activity by FSH-
induced POR expression in ovarian granulosa cells. POR
knockout mice are embryonically lethal, but POR hetero-
zygous knockout mice are fertile, and do not have ambig-
uous genitalia [50]. Our study suggests that a comparison
of ovarian function and morphology between POR heter-
ozygous knockout mice and aromatase knockout mice
[51] could provide further useful information. In addi-
tion, POR might be involved in the differentiation of
these steroidogenic organs through activation of micro-
somal P450 enzymes.
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